Rodin Therapeutics

Rodin Therapeutics

Develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Launch date
Employees
Market cap
-
Enterprise valuation
€98—147m (Dealroom.co estimates Sep 2017.)
Cambridge Massachusetts (HQ)
Authorizing premium user...